Citadel Advisors’s HUMANIGEN, INC. HGEN Stock Holding History

Citadel Advisors’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$14	–	15601
2023 Q1	$14	Buy	+100	New	+$16	﹤0.01%	14620
2022 Q3	–	Sell	-48,200	Closed	-$85K	–	13997
2022 Q2	$85K	Sell	48,200 -66,500	-58%	-$149K	﹤0.01%	11557
2022 Q1	$345K	Buy	114,700 +68,300	+147%	+$183K	﹤0.01%	10275
2021 Q4	$173K	Sell	46,400 -35,400	-43%	-$207K	﹤0.01%	12073
2021 Q3	$485K	Sell	81,800 -85,000	-51%	-$1.19M	﹤0.01%	9947
2021 Q2	$2.9M	Sell	166,800 -77,900	-32%	-$1.42M	﹤0.01%	5687
2021 Q1	$4.67M	Buy	244,700 +169,600	+226%	+$3.1M	﹤0.01%	4398
2020 Q4	$1.31M	Buy	+75,100	New	+$899K	﹤0.01%	6212

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Citadel Advisors's HGEN Position: Q3 2023 in Review

Citadel Advisors sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 24,586 shares — an estimated $3.75K sold.

Citadel Advisors first reported a position in HGEN in Q3 2020 and held it in 11 quarters. The position peaked at $14M in Q3 2020. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Citadel Advisors reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 24,586 HUMANIGEN, INC. shares in Q3 2023, an estimated $3.75K.
Citadel Advisors first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 11 quarters.
Citadel Advisors's HUMANIGEN, INC. position peaked at $14M in Q3 2020.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.